DK2602326T3 - Fremgangsmåder til transficering af nukleinsyrer til levende celler - Google Patents

Fremgangsmåder til transficering af nukleinsyrer til levende celler Download PDF

Info

Publication number
DK2602326T3
DK2602326T3 DK13156520.2T DK13156520T DK2602326T3 DK 2602326 T3 DK2602326 T3 DK 2602326T3 DK 13156520 T DK13156520 T DK 13156520T DK 2602326 T3 DK2602326 T3 DK 2602326T3
Authority
DK
Denmark
Prior art keywords
cell
cells
nucleic acid
mrna
recipient
Prior art date
Application number
DK13156520.2T
Other languages
English (en)
Inventor
James Eberwine
Hajime Takano
Fanyi Zeng
Philip G Haydon
Jai-Yoon Sul
Kitty Chia-Wen Wu
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Application granted granted Critical
Publication of DK2602326T3 publication Critical patent/DK2602326T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1079Screening libraries by altering the phenotype or phenotypic trait of the host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Claims (12)

1. In vitro- eller ex v/Vo-fremgangsmåde til at overføre en multigen fænotype fra en donorcelle til en modtagercelle ved: at transficere en modtagercelle med totalt mRNA fra en donorcelle, hvor donorcellen er af den samme art som modtagercellen, hvor fænotypen af donorcellen er forskellig fra fænotypen af modtagercellen, hvor mRNA'erne trænger ind i modtagercellen, hvor mRNA'erne er funktionelle i modtagercellen, og hvor mRNA'erne udløser en ændring i morfologi og fysiologi i modtagercellen, og hvor ændringen giver en fænotype, som er angivende for donorcellen.
2. Fremgangsmåde ifølge krav 1, hvor modtagercellen er en eukaryotisk celle.
3. Fremgangsmåde ifølge krav 1, hvor modtagercellen er en pattedyrscelle.
4. Fremgangsmåde ifølge krav 1, hvor modtagercellen er udvalgt fra gruppen bestående af en epithelial-celle, en neuron, en fibroblast, en embryonisk fibroblast, en keratinocyt, en voksen stamcelle, en embryonisk stamcelle, en astrocyt og en cardiomyocyt.
5. Fremgangsmåde ifølge krav 1, hvor fremgangsmåden yderligere omfatter at transficere modtagercellen med mindst et DNA fra donorcellen.
6. Fremgangsmåde ifølge krav 5, hvor fremgangsmåden yderligere omfatter at transficere modtagercellen med mindst et udvalgt fra gruppen bestående af siRNA, miRNA, hnRNA og tRNA.
7. Fremgangsmåde ifølge krav 1, hvor det totale mRNA eksprimeres af modtagercellen.
8. Fremgangsmåde ifølge krav 1, hvor det totale mRNA isoleres fra en donorcelle.
9. Fremgangsmåde ifølge krav 8, hvor donorcellen er udvalgt fra gruppen bestående af: en astrocyt, en cardiomyocyt, en neonatal cardiomyocyt, en embryonisk stamcelle og en neuron.
10. Fremgangsmåde ifølge krav 1, hvor det totale mRNA fremstilles ved hjælp af en fremgangsmåde, der er udvalgt fra gruppen bestående af: isolering fra en donorcelle, in vitro-transkription eller kemisk syntese.
11. Fremgangsmåde ifølge krav 10, hvor det totale mRNA er in v7fro-transkri-beret.
12. In vitro- eller ex vivo-fremgangsmåde ifølge krav 1, kendetegnet ved at transficere modtagercellen sekventielt med totalt mRNA fra en donorcelle på et første tidspunkt, og derefter at transficere cellen på et andet eller efterfølgende tidspunkt.
DK13156520.2T 2005-12-13 2006-12-12 Fremgangsmåder til transficering af nukleinsyrer til levende celler DK2602326T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74994105P 2005-12-13 2005-12-13
EP06849313.9A EP1963514B1 (en) 2005-12-13 2006-12-12 Methods for phototransfecting nucleic acid into live cells

Publications (1)

Publication Number Publication Date
DK2602326T3 true DK2602326T3 (da) 2018-12-10

Family

ID=38288081

Family Applications (3)

Application Number Title Priority Date Filing Date
DK18190026.7T DK3467112T3 (da) 2005-12-13 2006-12-12 Fremgangsmåder til transfektion af nukleinsyrer til levende celler
DK13156520.2T DK2602326T3 (da) 2005-12-13 2006-12-12 Fremgangsmåder til transficering af nukleinsyrer til levende celler
DK06849313.9T DK1963514T3 (da) 2005-12-13 2006-12-12 Fremgangsmåder til fototransferering af nukleinsyre til levende celler

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK18190026.7T DK3467112T3 (da) 2005-12-13 2006-12-12 Fremgangsmåder til transfektion af nukleinsyrer til levende celler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06849313.9T DK1963514T3 (da) 2005-12-13 2006-12-12 Fremgangsmåder til fototransferering af nukleinsyre til levende celler

Country Status (5)

Country Link
US (3) US10646590B2 (da)
EP (3) EP2602326B1 (da)
DK (3) DK3467112T3 (da)
ES (2) ES2433669T3 (da)
WO (1) WO2007084228A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3467112T3 (da) 2005-12-13 2020-11-30 Univ Pennsylvania Fremgangsmåder til transfektion af nukleinsyrer til levende celler
US9157066B2 (en) 2005-12-13 2015-10-13 The Trustees Of The University Of Pennsylvania Transcriptome transfer produces cellular phenotype conversion
US10647960B2 (en) 2005-12-13 2020-05-12 The Trustees Of The University Of Pennsylvania Transcriptome transfer produces cellular phenotype conversion
WO2010118045A1 (en) * 2009-04-07 2010-10-14 The Trustees Of The University Of Pennsylvania Transcriptome transfer produces cellular phenotype conversion
GB201009800D0 (en) * 2010-06-11 2010-07-21 Univ St Andrews Optical transfection
US9717927B2 (en) * 2013-02-07 2017-08-01 Rocomp Global, L.L.C. Electromagnetic radiation targeting devices, assemblies, systems and methods

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711262A (en) 1970-05-11 1973-01-16 Corning Glass Works Method of producing optical waveguide fibers
DE3483934D1 (de) 1983-10-13 1991-02-21 Rikagaku Kenkyusho Verfahren und apparat zum einpflanzen eines fremdstoffes in lebende zelle.
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5246437A (en) 1992-04-10 1993-09-21 Abela George S Cell treatment apparatus and method
US5665565A (en) 1994-07-12 1997-09-09 The University Of Virginia Patent Foundation Transfection of enteric parasites
US6096716A (en) 1994-12-12 2000-08-01 The Board Of Regents, The University Of Texas System Liposome-mediated transfection of central nervous system cells
US6753161B2 (en) 1997-03-27 2004-06-22 Oncosis Llc Optoinjection methods
EP1021549A2 (en) * 1997-09-19 2000-07-26 Sequitur, Inc. SENSE mRNA THERAPY
AU760113C (en) 1997-11-18 2004-04-22 Pioneer Hi-Bred International, Inc. Compositions and methods for genetic modification of plants
US20040180430A1 (en) 1999-09-07 2004-09-16 West Michael D. Methods of restoring telomere length and extending cell lifespan using nuclear transfer
DE69923840T2 (de) * 1999-09-09 2006-04-06 Curevac Gmbh Transfer von mRNAs unter Verwendung von polykationischen Verbindungen
KR101215789B1 (ko) 2000-03-30 2012-12-26 화이트헤드 인스티튜트 포 바이오메디칼 리서치 Rna 간섭의 rna 서열 특이적인 매개체
JP2002325572A (ja) * 2000-12-25 2002-11-12 Univ Osaka 外来物質の導入方法
GB0111015D0 (en) * 2001-05-04 2001-06-27 Norsk Hydro As Genetic material
EP1270732A1 (en) * 2001-06-21 2003-01-02 Schuler, Gerold Improved transfection of eukaryontic cells with linear polynucleotides by electroporation
WO2003079883A2 (en) * 2002-03-27 2003-10-02 Hadasit Medical Research Services And Development Ltd. Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage
EP1391503A1 (en) * 2002-08-12 2004-02-25 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts A method of cell re-programming by cytoplasmic transfer
US20050095578A1 (en) 2003-10-31 2005-05-05 Koller Manfred R. Method and apparatus for cell permeabilization
JP4681279B2 (ja) * 2003-11-17 2011-05-11 独立行政法人科学技術振興機構 細胞外物質の細胞内への導入方法
US6973245B2 (en) 2003-12-30 2005-12-06 Furukawa Electric North America Optical fiber cables
WO2005068495A1 (ja) 2004-01-13 2005-07-28 Toray Industries, Inc. クモ糸タンパク質を含む絹糸および該絹糸を産生するカイコ
GB0426182D0 (en) 2004-11-30 2004-12-29 Univ St Andrews Photoporation of cells
US20070087437A1 (en) * 2005-10-14 2007-04-19 Jifan Hu Methods for rejuvenating cells in vitro and in vivo
US9157066B2 (en) 2005-12-13 2015-10-13 The Trustees Of The University Of Pennsylvania Transcriptome transfer produces cellular phenotype conversion
DK3467112T3 (da) 2005-12-13 2020-11-30 Univ Pennsylvania Fremgangsmåder til transfektion af nukleinsyrer til levende celler
US10647960B2 (en) * 2005-12-13 2020-05-12 The Trustees Of The University Of Pennsylvania Transcriptome transfer produces cellular phenotype conversion
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor

Also Published As

Publication number Publication date
ES2433669T3 (es) 2013-12-12
DK1963514T3 (da) 2013-11-04
US20200206364A1 (en) 2020-07-02
WO2007084228A2 (en) 2007-07-26
US10646590B2 (en) 2020-05-12
EP3467112B1 (en) 2020-11-18
DK3467112T3 (da) 2020-11-30
EP3467112A2 (en) 2019-04-10
EP1963514B1 (en) 2013-08-14
US20120135493A1 (en) 2012-05-31
EP3467112A3 (en) 2019-05-22
EP1963514A4 (en) 2010-05-19
ES2698600T3 (es) 2019-02-05
EP2602326B1 (en) 2018-08-22
US10583204B2 (en) 2020-03-10
WO2007084228A3 (en) 2008-06-12
EP2602326A1 (en) 2013-06-12
US20120178167A1 (en) 2012-07-12
EP1963514A2 (en) 2008-09-03

Similar Documents

Publication Publication Date Title
US20200206364A1 (en) Methods for Transfecting Nucleic Acid Into Live Cells
US9845480B2 (en) Transcriptome transfer produces cellular phenotype conversion
US20200270633A1 (en) Transcriptome transfer produces cellular phenotype conversion
EP2845010A2 (en) Mesenchymal stem cells for in vitro modeling and cell-based therapy of human diseases and banks thereof
US20210031186A1 (en) High throughput microfluidic device
JP2022525193A (ja) Prpf31遺伝子発現ノックダウンによる、インビトロで分化したヒト細胞の生存の改善
Pratico et al. RNA-mediated reprogramming of primary adult human dermal fibroblasts into c-Kit+ cardiac progenitor cells
US20200225213A1 (en) Compositions and methods for detecting cardiotoxicity
JP2021528984A (ja) 成体幹細胞の拡大と誘導のインビトロでの誘発
Rios et al. Gene loss-of-function and live imaging in chick embryos
Begum et al. An Optimized Protocol of Electroporation of Hepatocyte Nuclear Factor 1 Alpha (Hnf-1 α) in Mesenchymal Stem Cells
WO2010118045A1 (en) Transcriptome transfer produces cellular phenotype conversion
EP3699267A1 (en) Method for obtaining artificial neuromuscular junction from pluripotent stem cells
Geay et al. Plakins are involved in the maintenance of epithelial polarity
US20210079440A1 (en) HIGH EXPRESSION mRNA SWITCH
KR20200137636A (ko) 마이크로rna의 비정규 표적을 억제하는 rna 간섭 유도 핵산 및 그 용도
NDODO MPG-mediated delivery of small RNAs into human mesenchymal stem cells during proliferation and adipocyte differentiation
Zeitelhofer Investigating the role of different ribonucleoprotein particles in dendritic mRNA localization and translational control
Digruber Loss-of-function of a Mitochondrial Transport Protein in Human Adipocytes